Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2009 Sep;53(9):3611-9.
doi: 10.1128/AAC.00154-09. Epub 2009 May 26.

Antiretroviral drug resistance in human immunodeficiency virus type 2

Michel L Ntemgwa  1 , Thomas d'Aquin Toni, Bluma G Brenner, Ricardo J Camacho, Mark A Wainberg
Affiliations
Review

Antiretroviral drug resistance in human immunodeficiency virus type 2

Michel L Ntemgwa et al. Antimicrob Agents Chemother. 2009 Sep.
No abstract available

PubMed Disclaimer

Figures

FIG. 1.
FIG. 1.
Amino acid differences between HIV-1 and HIV-2 PR. Shaded areas are those with polymorphisms at positions known to be involved in HIV-1 PI resistance. Dots indicate homology.
FIG. 2.
FIG. 2.
Amino acid differences between HIV-1 and HIV-2 RT. Shaded areas are those with polymorphisms at positions known to be involved in HIV-1 NRTI/NNRTI resistance. Dots indicate homology.
See this image and copyright information in PMC

References

    1. Adje-Toure, C. A., R. Cheingsong, J. G. Garcia-Lerma, S. Eholie, M. Y. Borget, J. M. Bouchez, R. A. Otten, C. Maurice, M. Sassan-Morokro, R. E. Ekpini, M. Nolan, T. Chorba, W. Heneine, and J. N. Nkengasong. 2003. Antiretroviral therapy in HIV-2-infected patients: changes in plasma viral load, CD4+ cell counts, and drug resistance profiles of patients treated in Abidjan, Cote d'Ivoire. AIDS 17(Suppl. 3):S49-S54. - PubMed
    1. Andreasson, P. A., F. Dias, A. Naucler, S. Andersson, and G. Biberfeld. 1993. A prospective study of vertical transmission of HIV-2 in Bissau, Guinea-Bissau. AIDS 7:989-993. - PubMed
    1. Andries, K., H. Azijn, T. Thielemans, D. Ludovici, M. Kukla, J. Heeres, P. Janssen, B. De Corte, J. Vingerhoets, R. Pauwels, and M. P. de Bethune. 2004. TMC125, a novel next-generation nonnucleoside reverse transcriptase inhibitor active against nonnucleoside reverse transcriptase inhibitor-resistant human immunodeficiency virus type 1. Antimicrob. Agents Chemother. 48:4680-4686. - PMC - PubMed
    1. Barre-Sinoussi, F., J. C. Chermann, F. Rey, M. T. Nugeyre, S. Chamaret, J. Gruest, C. Dauguet, C. Axler-Blin, F. Vezinet-Brun, C. Rouzioux, W. Rozenbaum, and L. Montagnier. 2004. Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS). 1983. Rev. Invest Clin. 56:126-129. - PubMed
    1. Blaak, H., P. H. Boers, R. A. Gruters, H. Schuitemaker, M. E. van der Ende, and A. D. Osterhaus. 2005. CCR5, GPR15, and CXCR6 are major coreceptors of human immunodeficiency virus type 2 variants isolated from individuals with and without plasma viremia. J. Virol. 79:1686-1700. - PMC - PubMed

Publication types

MeSH terms

LinkOut - more resources